doi: 10.1007/s13300-024-01674-8 Retrieved from Novo Nordisk-a
Semaglutide Major trials demonstrated an average weight loss of between 15 and 17 percent of the participants starting weight over a 68-week time frame
Consistently, in a more recent meta-analysis of 40 randomized controlled trials performed in patients with T2DM, compared with standard diabetes therapies (i.e., metformin, sulfonylureas, insulin, DPP-4i, thiazolidinediones) and placebo, GLP-1RA therapy was associated with significant reductions in inflammatory markers such as serum C-reactive protein (CRP) and TNF-, and a significant increase in adiponectin [80]
Everett, B
in Psychology, Maryland University Baltimore County Obesity Medical Association Member NCCPA Certification Learn More Kelsey Furstenberg Nurse Practitioner in Ellicott City M.S
Taking these two together is not only safe, but it can also be a strategic move for your long-term health